Measurement of Bladder Pressure With a Novel External Device, Comparison to Urodynamics Testing
Launched by CHRISTOPHER COOPER · Mar 6, 2018
Trial Information
Current as of August 24, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
For patients with neurogenic bladder, regular monitoring of bladder pressure and capacity is a critical component of maintaining renal and urinary health. This monitoring is currently done by in-office urodynamics testing (UDS). This testing is done intermittently, leaving open the possibility of worsening of bladder function and renal deterioration between testing sessions.
This study utilizes a novel pressure monitoring device which is portable and hooks to the end of a standard urinary catheter. The investigators will be investigating if this device can achieve similar pressure measurem...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • must have diagnosed neurogenic bladder
- • undergoing urodynamics testing as part of routine clinical care
- Exclusion Criteria:
- • -None
About Christopher Cooper
Christopher Cooper is a dedicated clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With a robust background in clinical development and regulatory affairs, he leads initiatives that prioritize innovation and ethical standards in trial management. His expertise encompasses a range of therapeutic areas, and he collaborates closely with research institutions and healthcare professionals to ensure the successful execution of clinical studies. Under his leadership, the organization fosters a culture of transparency, rigor, and collaboration, aimed at delivering impactful healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Iowa City, Iowa, United States
Patients applied
Trial Officials
Chris Cooper, MD
Principal Investigator
MD
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials